BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2205100)

  • 1. C-myc proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas.
    Schreiber G; Dubeau L
    Am J Pathol; 1990 Sep; 137(3):653-8. PubMed ID: 2205100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
    Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
    Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
    Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
    Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of rearrangements in the first exon of c-myc oncogene in squamous cell carcinoma of the head and neck].
    Rodrigo Tapia JP; Lazo PS; Ramos S; Alvarez Alvarez I; Suárez Nieto C
    Acta Otorrinolaringol Esp; 1995; 46(4):287-92. PubMed ID: 7546854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
    Abou-Elella A; Gramlich T; Fritsch C; Gansler T
    Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.
    Wu R; Lin L; Beer DG; Ellenson LH; Lamb BJ; Rouillard JM; Kuick R; Hanash S; Schwartz DR; Fearon ER; Cho KR
    Am J Pathol; 2003 May; 162(5):1603-10. PubMed ID: 12707044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
    Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
    Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene amplification in archival tissue by differential polymerase chain reaction.
    Neubauer A; Neubauer B; He M; Effert P; Iglehart D; Frye RA; Liu E
    Oncogene; 1992 May; 7(5):1019-25. PubMed ID: 1349162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-step "hot" PCR amplification of GC-rich avian c-myc sequences.
    Schuchard M; Sarkar G; Ruesink T; Spelsberg TC
    Biotechniques; 1993 Mar; 14(3):390-4. PubMed ID: 8457343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.